- Fund Type: Unit Trust
- Objective: Sector Fund-Health & Biotech
- Asset Class: Equity
- Geographic Focus: Global
Allianz Global Investors Global Biotech Fund
+ Add to WatchlistDREGBIO:TT
22.92 TWD 0.42 1.80%As of 22:30:00 ET on 05/16/2013.
Snapshot for Allianz Global Investors Global Biotech Fund (DREGBIO)
| Year To Date: | +33.41% | 3-Month: | +17.96% | 3-Year: | +20.50% | 52-Week Range: | 15.82 - 23.40 |
|---|---|---|---|---|---|---|---|
| 1-Month: | +5.33% | 1-Year: | +40.18% | 5-Year: | +11.79% | Beta vs TWSE: | 0.68 |
Fund Profile & Information for DREGBIO
Allianz Global Investors Global Biotech Fund is an open-end unit trust establish ed in Taiwan. The Fund's objective is to seek long-term capital gain and secure stable income. The Fund invests primarily in equity securities issued by companies in the biotechnology sector. It also invests in local equities and government bonds (including convertibles) and financial debentures.
| Inception Date: | 06-28-2002 | Telephone: | 886-2-2502-8889 |
|---|---|---|---|
| Managers: | FU TZU-PING "MARK" | ||
| Web Site: | www.allianzglobalinvestors.com.tw | ||
Fundamentals for DREGBIO
| NAV | (on 2013-05-16) 22.92 |
|---|---|
| Assets (M) | (on 2013-04-30) 2,128.11 |
| Fund Leveraged | N |
| Minimum Investment | 10,000.00 |
| Minimum Subsequent Investment | 3,000.00 |
Dividends for DREGBIO
No dividends reported
Fees & Expenses for DREGBIO
| Front Load | 2.00 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 1.80 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for DREGBIO
Holding Data Unavailable.
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page